| Naziv |
Akcije |
| Mišura Jakobac, Karla ; Duić, Tihana ; Bojanić, Ana ; Aćamović Stipinović, Bojana ; Mandac Smoljanović, Inga ; Ostojić Kolonić, Slobodanka ; Pomper, Ljiljana ; Radić Krišto, Delfa
Autologna transplantacija krvotvornih matičnih stanica u multiplom mijelomu // Medix (Zagreb), 155 (2022), 28; 1-1 |
|
| Tkalčić Švabek, Željka ; Horvat, Martina ; Mišura Jakobac, Karla ; Mandac Smoljanović, Inga ; Kardum Paro, Mirjana Mariana
FLT3/ITD pozitivna B-akutna limfoblastična leukemija - prikaz slučaja // Bilten Krohema, 14 (2022), 2; 22-25 |
|
| Bašić-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić-Petričević, Jasminka ; Deak, Dajana ; Vodanović, Marijo ; Jakić-Bubalo, Marinka ; Mitrović, Zdravko ; Grubešić, Aron ; Dreta, Barbara ; Županić Krmek, Dubravka et al.
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non internventional study of the Croatian Cooperative Group for Hematologic Diseases // Croatian medical journal, 62 (2021), 5; 455-463. doi: 10.3325/cmj.2021.62.455-63 |
|
| Milunović, Vibor ; Žalac, Klara ; Brcić, Hrvoje ; Zimak, Romyna ; Mišura Jakobac, Karla ; Mandac Rogulj, Inga ; Kursar, Marin ; Martinović, Marko ; Radić Krišto, Delfa ; Ostojić Kolonić, Slobodanka
Determinants of quality of life in multiple myeloma patients: Croatian experience // HemaSphere. 2020. str. 809-810 doi: 10.1097/HS9.0000000000000404 |
|
| Aurer, Igor ; Jakšić, Ozren ; Basic-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić-Petričević, Jasminka ; Novaković Coha, Sabina ; Galušić, Davor ; Holik, Hrvoje ; Valković, Toni ; Županić-Krmek, Dubravka et al.
Feasibility of obinutuzumab (G) combined with higher doses of chlorambucil (Clb) for frontline treatment of CLL: a retrospective non-interventional study of KroHem, the Croatian Cooperative Group for Hematologic Diseases // Leukemia & lymphoma. 2020. str. 111-112 doi: 10.1080/10428194.2020.1732667 |
|
| Mandac Rogulj, Inga ; Kardum Paro, Mirjana Mariana ; Milunović, Vibor ; Mišura Jakobac, Karla ; Zatezalo, Viktor ; Aćamović Stipinović, Bojana ; Bogeljić Patekar, Martina ; Kursar, Marin ; Martinović, Marko ; Rinčić, Goran et al.
MICRORNA 99B and LET7A as diagnostic parameters in myelodysplastic syndrome // HemaSphere. 2020. str. 899-899 doi: 10.1097/HS9.0000000000000404 |
|
| Aurer, Igor ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić- Petričević, Jasminka ; Novaković Coha, Sabina ; Galušić, Davor ; Holik, Hrvoje ; Valković, Toni ; Županić-Krmek, Dubravka et al.
Podnošljivost kombinacija obinutuzumaba i viših doza klorambucila u prvoj liniji liječenja kronične limfocitne leukemije // Bilten Krohema, 12 (2020), 1; 23-23 |
|
| Milunović, Vibor ; Mišura Jakobac, Karla ; Mandac Rogulj, Inga ; Martinović, Marko ; Radić-Krišto, Delfa ; Ostojić Kolonić, Slobodanka
The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia – are we ready for chemo-free immunotherapy approach? // Expert review of hematology, 13 (2020), 7; 771-779. doi: 10.1080/17474086.2020.1775575 |
|
| Aurer, Igor ; Mišura Jakobac, Karla ; Sinčić- Petricevic, Jasminka ; Deak, Dajana, Vodanović, Mario ; Jakic-Bubalo, Marina ; Mitrović, Zdravko ; Grubesic Aron ; Dreta Barbara ; Zupanic-Krmek, Dubravka, Coha Božena
IMPROVEMENTS IN OUTCOME OF MANTLE-CELL LYMPHOMA (MCL) ARE MOSTLY DUE TO ADVANCES IN INDUCTION THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) - A REAL-LIFE NON- INTERVENTIONAL STUDY OF KROHEM // HemaSphere. 2019. str. 579-579 doi: 10.1097/01.HS9.0000563340.44346.69 |
|
| Milunović, Vibor ; Mišura Jakobac, Karla ; Kursar, Marin ; Mandac Rogulj, Inga ; Ostojić Kolonić, Slobodanka
FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town? // European journal of haematology, 103 (2019), 3; 145-151. doi: 10.1111/ejh.13269 |
|
